Objective To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of
HPV infection and recurrent diseases related to HPV infection in individuals undergoing …

Objective: To assess evidence on the efficacy of adjuvant human papillomavirus (HPV)
vaccination in patients treated for HPV-related disease across different susceptible organ …

Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …

Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on
the risk of developing subsequent disease after an excisional procedure for cervical …

Introduction Human papillomavirus (HPV) vaccination is essential for cervical cancer
prevention. However, the value of HPV vaccination in the context excisional treatment of …

We evaluated the efficacy of the human papillomavirus (HPV)− 16/18 AS04‐adjuvanted
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-
grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to …

Background The German Standing Committee on Vaccination (STIKO) recommends
vaccination against human papillomaviruses (HPV) of the high-risk types 16 and 18. The …

Data suggest that adjuvant human papillomavirus (HPV)-vaccination in women treated for
cervical HPV diseases reduces recurrent disease. This study investigates adjuvant HPV …

OBJECTIVE: To perform a systematic review and meta-analysis evaluating the efficacy of
adjuvant human papillomavirus (HPV) vaccination in preventing recurrent cervical …